Literature DB >> 19106213

Abnormal autoregulation and tubuloglomerular feedback in prediabetic and diabetic OLETF rats.

Seiji Hashimoto1, Kanji Yamada, Tetsuya Kawata, Toshio Mochizuki, Jurgen Schnermann, Takao Koike.   

Abstract

The mechanisms underlying the development and prevention of diabetic nephropathy are still not fully understood. In the present study in the Otsuka Long-Evans Tokushima Fatty (OLETF) model of type 2 diabetic rats, we investigated whether renal hemodynamic abnormalities exist and whether they precede the onset of diabetes. Using OLETF rats in both prediabetic and diabetic stages, we assessed autoregulatory responses of total renal blood flow (RBF) and of superficial (SBF) and deep renal cortical (DBF) blood flow to stepwise reductions of renal perfusion pressure (RPP) induced by a manual clamp on the abdominal aorta. During clamp-induced reductions of RPP by 10 or 20 mmHg, RBF fell significantly more in OLETF rats than in lean control [Long-Evans Tokushima Otsuka (LETO)] rats. Whereas SBF showed no significant changes in either OLETF rats or LETO rats during mild clamping, DBF decreased significantly more in OLETF rats than LETO rats. Reduced autoregulatory efficiency in OLETF rats was observed in both prediabetic and diabetic stages. Micropuncture studies showed that tubuloglomerular feedback (TGF) responses of stop flow pressure are reduced in prediabetic (-7.3 vs. -25.7%) as well as in diabetic OLETF rats compared with LETO control rats (-4.4 vs. -18.8%). Renal corticotomy was performed to measure glomerular capillary pressure (Pgc) directly. Pgc of deep cortical glomeruli was higher than superficial glomerular Pgc in both strains of rats, but the difference was especially pronounced in OLETF rats (deep 78 +/- 2 vs. superficial 57 +/- 4 mmHg). This study demonstrates reduced autoregulatory adjustments and impaired TGF efficiency in prediabetic OLETF rats. Thus abnormal RBF regulation precedes the onset of diabetes and is especially pronounced in the deep cortical region.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19106213     DOI: 10.1152/ajprenal.00074.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  10 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  Defective renal autoregulation in the chronic bile duct ligation model of liver failure.

Authors:  Tomchika Maoka; Tetsuya Kawata; Takao Koike; Toshio Mochizuki; Jurgen Schnermann; Seiji Hashimoto
Journal:  Clin Exp Nephrol       Date:  2018-03-07       Impact factor: 2.801

3.  AT2 receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats.

Authors:  Quaisar Ali; Tahir Hussain
Journal:  Hypertens Res       Date:  2012-02-02       Impact factor: 3.872

Review 4.  Scope and mechanisms of obesity-related renal disease.

Authors:  Tracy E Hunley; Li-Jun Ma; Valentina Kon
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

Review 5.  The renal vascular response to diabetes.

Authors:  Pamela K Carmines
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-01       Impact factor: 2.894

6.  Estimation of Intraglomerular Pressure Using Invasive Renal Arterial Pressure and Flow Velocity Measurements in Humans.

Authors:  Didier Collard; Peter M van Brussel; Lennart van de Velde; Gilbert W M Wijntjens; Berend E Westerhof; John M Karemaker; Jan J Piek; Jim A Reekers; Liffert Vogt; Robbert J de Winter; Bert-Jan H van den Born
Journal:  J Am Soc Nephrol       Date:  2020-06-16       Impact factor: 10.121

7.  Nephron filtration rate and proximal tubular fluid reabsorption in the Akita mouse model of type I diabetes mellitus.

Authors:  Jurgen Schnermann; Mona Oppermann; Yuning Huang
Journal:  F1000Res       Date:  2013-03-11

8.  Roles of Insulin Receptor Substrates (IRS) in renal function and renal hemodynamics.

Authors:  Seiji Hashimoto; Tomochika Maoka; Tetsuya Kawata; Toshio Mochizuki; Takao Koike; Takashi Shigematsu
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

9.  Pioglitazone in diabetic kidney disease: forgotten but not gone.

Authors:  Georgios S Papaetis
Journal:  Arch Med Sci Atheroscler Dis       Date:  2022-08-08

10.  An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF Rats.

Authors:  Masanori Nozako; Takashi Koyama; Chifumi Nagano; Makoto Sato; Satoshi Matsumoto; Kiminobu Mitani; Reiko Yasufuku; Masayuki Kohashi; Tomohiro Yoshikawa
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.